Pressure Biosciences Inc (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,084 | -3,450 | -2,996 | -3,128 | -2,560 |
| Depreciation Amortization | 1,269 | 688 | 250 | 197 | 200 |
| Accounts receivable | 69 | 85 | -45 | -31 | N/A |
| Accounts payable and accrued liabilities | -97 | 309 | 764 | 87 | N/A |
| Other Working Capital | 450 | 568 | 753 | -215 | 70 |
| Other Operating Activity | 52 | -365 | -868 | 217 | 490 |
| Operating Cash Flow | $-2,343 | $-2,165 | $-2,142 | $-2,872 | $-1,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -59 | N/A | -3 | -92 | -150 |
| Investing Cash Flow | $-59 | $N/A | $-3 | $-92 | $-150 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,374 | 1,394 | 412 | N/A | N/A |
| Debt Issued | 222 | 99 | N/A | N/A | N/A |
| Debt Repayment | -530 | -102 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 378 | 44 | 1,442 | N/A |
| Dividend Paid | -60 | -197 | N/A | N/A | 0 |
| Other Financing Activity | 1,425 | 372 | 1,358 | 466 | 2,700 |
| Financing Cash Flow | $2,431 | $1,944 | $1,814 | $1,907 | $2,700 |
| Beginning Cash Position | 2 | 223 | 553 | 1,610 | 860 |
| End Cash Position | 31 | 2 | 223 | 553 | 1,610 |
| Net Cash Flow | $30 | $-221 | $-330 | $-1,057 | $740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,343 | -2,165 | -2,142 | -2,872 | -1,800 |
| Capital Expenditure | -59 | N/A | -3 | -92 | N/A |
| Free Cash Flow | -2,401 | -2,165 | -2,145 | -2,964 | -1,800 |